Last reviewed · How we verify

NCT04174235

Prevalence of Fetal Congenital Anomalies Among Pregnant Women Attending University Hospital

Completed Last updated 22 November 2019
What this trial tests

trial testing Ultrasound scan in Fetal Anomaly in 20,225 participants. Completed in 14 January 2019.

Timeline
14 January 2016
Primary endpoint
14 January 2019
14 January 2019

Quick facts

Lead sponsorBeni-Suef University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment20,225
Start date14 January 2016
Primary completion14 January 2019
Estimated completion14 January 2019
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Beni-Suef University

Who can join

Adults 18 to 40, female only, with Fetal Anomaly. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Congenital anomalies occur in 2-3% of births. They account for 20-30% of perinatal deaths. The aim is to assess the prevalence of fetal malformations in pregnant women attending University hospital

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ultrasound scan

Trials testing the same drug.

Other recruiting trials for Fetal Anomaly

Currently open trials in the same condition.

Other Beni-Suef University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04174235.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing